TNFSF11 and B-cell chronic lymphocytic leukemia: Interestingly, the receptor activator of nuclear factor kappa beta ligand (RANKL) is expressed and released by CLL cells, contributing to the cytokine milieu related to disease activity and reduction in osteoclastogenesis [10].